NO20044448L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20044448L
NO20044448L NO20044448A NO20044448A NO20044448L NO 20044448 L NO20044448 L NO 20044448L NO 20044448 A NO20044448 A NO 20044448A NO 20044448 A NO20044448 A NO 20044448A NO 20044448 L NO20044448 L NO 20044448L
Authority
NO
Norway
Prior art keywords
new connections
connections
new
drug
Prior art date
Application number
NO20044448A
Other languages
English (en)
Norwegian (no)
Inventor
Xiao-Qing Lewell
Lee Andrew Harrison
Suzanne Elaine Keeling
Stephen Swanson
Rachael Anne Ancliff
Caroline Mary Cook
Colin David Eldred
Paul Martin Gore
Simon Tennby Hodgson
Graeme Michael Robertson
Martin Alistair Hayes
Gail Mills
Andrew John Walker
Mark Wilkinson
Duncan Bruce Judd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0207434A external-priority patent/GB0207434D0/en
Priority claimed from GB0301608A external-priority patent/GB0301608D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20044448L publication Critical patent/NO20044448L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20044448A 2002-03-28 2004-10-19 Nye forbindelser NO20044448L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0207434A GB0207434D0 (en) 2002-03-28 2002-03-28 Novel compounds
GB0301608A GB0301608D0 (en) 2003-01-24 2003-01-24 Novel compounds
PCT/EP2003/003335 WO2003082861A2 (en) 2002-03-28 2003-03-27 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
NO20044448L true NO20044448L (no) 2004-10-26

Family

ID=28676494

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044448A NO20044448L (no) 2002-03-28 2004-10-19 Nye forbindelser

Country Status (23)

Country Link
US (1) US7622464B2 (sl)
EP (1) EP1487828B1 (sl)
JP (1) JP4465195B2 (sl)
KR (1) KR20040093488A (sl)
CN (1) CN1656092A (sl)
AR (1) AR040403A1 (sl)
AT (1) ATE413399T1 (sl)
AU (1) AU2003226757A1 (sl)
BR (1) BR0308780A (sl)
CA (1) CA2480106A1 (sl)
CY (1) CY1108652T1 (sl)
DE (1) DE60324535D1 (sl)
DK (1) DK1487828T3 (sl)
ES (1) ES2315519T3 (sl)
IL (1) IL164047A0 (sl)
IS (1) IS7444A (sl)
MX (1) MXPA04009459A (sl)
NO (1) NO20044448L (sl)
PT (1) PT1487828E (sl)
RU (1) RU2004127928A (sl)
SI (1) SI1487828T1 (sl)
TW (1) TW200400035A (sl)
WO (1) WO2003082861A2 (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE552236T1 (de) 2003-01-14 2012-04-15 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
WO2004089296A2 (en) 2003-04-03 2004-10-21 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
JP2007532484A (ja) 2004-03-16 2007-11-15 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法
EA016138B1 (ru) 2004-06-17 2012-02-28 Цитокинетикс, Инк. Соединения, фармацевтические композиции и способы лечения сердечной недостаточности
US20090111730A1 (en) 2004-07-08 2009-04-30 Novo Nordisk A/S Polypeptide protracting tags
US7176222B2 (en) 2004-07-27 2007-02-13 Cytokinetics, Inc. Syntheses of ureas
CN101014580B (zh) 2004-09-08 2011-05-04 田边三菱制药株式会社 吗啉化合物
WO2006045119A2 (en) 2004-10-20 2006-04-27 The Regents Of The University Of California Improved inhibitors for the soluble epoxide hydrolase
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
TW200808321A (en) 2005-12-15 2008-02-16 Cytokinetics Inc Certain chemical entities, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
EP1959962A2 (en) 2005-12-16 2008-08-27 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US7989455B2 (en) 2005-12-19 2011-08-02 Cytokinetics, Inc. Compounds, compositions and methods
AR059826A1 (es) 2006-03-13 2008-04-30 Univ California Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
ES2748599T3 (es) * 2007-08-27 2020-03-17 Dart Neuroscience Cayman Ltd Compuestos terapéuticos de isoxazol
WO2012054093A2 (en) 2010-01-29 2012-04-26 The Regents Of The University Of California Acyl piperidine inhibitors of soluble epoxide hydrolase
RU2512293C1 (ru) * 2012-12-13 2014-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" Способ получения этил 1,2,4-оксадиазол-5-карбоксилатов
CN107362362B (zh) * 2017-07-20 2019-01-01 复旦大学 Sirt1抑制剂在预防和治疗放射引起的肠道疾病中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851526A (en) 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
JP3087763B2 (ja) * 1990-11-30 2000-09-11 三井化学株式会社 新規な複素環式化合物およびそれを含有する医薬組成物
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
CA2190501A1 (en) 1994-05-19 1995-11-30 Jose Luis Castro Pineiro Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
NZ290788A (en) 1994-07-20 1999-07-29 Byk Gulden Lomberg Chem Fab Piperazine thiopyridines; used for controlling helicobacter bacteria
US5654316A (en) 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
JP3531169B2 (ja) 1996-06-11 2004-05-24 三菱ウェルファーマ株式会社 縮合ヘテロ環化合物およびその医薬用途
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
IT1293807B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
US6031097A (en) * 1997-10-27 2000-02-29 Neurogen Corporation 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
WO1999021848A2 (en) 1997-10-27 1999-05-06 Neurogen Corporation Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
AU6280199A (en) 1998-09-30 2000-04-17 Neurogen Corporation 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands
EP1586567A1 (en) * 2000-09-29 2005-10-19 Glaxo Group Limited Compounds useful in the treatment of inflammatory diseases
PL362711A1 (en) 2000-09-29 2004-11-02 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
DK1487828T3 (da) 2009-02-02
AU2003226757A1 (en) 2003-10-13
PT1487828E (pt) 2009-01-06
US20060063765A1 (en) 2006-03-23
ATE413399T1 (de) 2008-11-15
EP1487828B1 (en) 2008-11-05
WO2003082861A2 (en) 2003-10-09
CN1656092A (zh) 2005-08-17
JP4465195B2 (ja) 2010-05-19
CY1108652T1 (el) 2014-08-13
IL164047A0 (en) 2005-12-18
EP1487828A2 (en) 2004-12-22
ES2315519T3 (es) 2009-04-01
KR20040093488A (ko) 2004-11-05
JP2005526815A (ja) 2005-09-08
BR0308780A (pt) 2004-12-28
IS7444A (is) 2004-09-13
MXPA04009459A (es) 2005-01-25
CA2480106A1 (en) 2003-10-09
DE60324535D1 (de) 2008-12-18
TW200400035A (en) 2004-01-01
RU2004127928A (ru) 2005-06-27
SI1487828T1 (sl) 2009-04-30
AR040403A1 (es) 2005-04-06
WO2003082861A3 (en) 2004-03-11
US7622464B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
NO20044597L (no) Kjemiske forbindelser
NO20044588L (no) Nye forbindelser
NO20044432L (no) Nye forbindelser
NO20044448L (no) Nye forbindelser
ITTO20030095A1 (it) Struttura di dispositivo antiurto.
NO20040014L (no) Nye forbindelser
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
NO20041003L (no) Nye forbindelser
NO20034665D0 (no) Nye forbindelser
ATE461217T1 (de) Glp-1-verbindungen
NO20091976L (no) Nye forbindelser
NO20034308L (no) Nye tyrokinase-inhibitorer
DK2062898T3 (da) Spirocykliske cyclohexan-derivater
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20034970D0 (no) Nye arylheteroalkylaminderivater
NO20045679D0 (no) Nye fysiologisk aktive substanser
DE502004000988D1 (de) Uv-stabiles transdermales pflaster
DK1626964T3 (da) Nye benzimidazolderivater
NO20063293L (no) Farmasoytiske forbindelser
NO20041185L (no) Nye sykloheksylsulfoner
NO20053071L (no) Kalsilytiske forbindelser.
DE60220667D1 (de) Stromquelle
NO20026285D0 (no) Nye peptider
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application